Is a complete ONCY research report available?

No complete published report is available for Oncolytics Biotech Inc. (ONCY) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

Oncolytics Biotech Inc. (ONCY)

NASDAQ: ONCY · USD

$0.75

+0.00 (+0.2%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-07-31 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first ONCY analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	89.9M
Net income (ttm)	-33.3M
EPS (ttm)	-$0.32
Shares out	119.4M
Volume	998,400
Beta	1.09
Price target	$5.05	+570.7%

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Net income (ttm): -33.3M
EPS (ttm): -$0.32
Market cap: 89.9M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
ALNY	Alnylam Pharmaceuticals, Inc.	27.4B	36.9x	5.7x	96.6%	+47.5%	-37.8%	Strong Buy
ARGX	argenx SE	53.8B	31.3x	10.1x	50.6%	+58.8%	+45.7%	Strong Buy
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

All ONCY indicators

Market & fundamental data

Available fields

188

Groups with data

Currency

USD

Showing 188 of 188 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001129928
Company name	Oncolytics Biotech Inc.
Country	United States
Country code	US
Cusip	68237V103
Employees	29
Employees Change	1%
Employees Change Percent	3.57
Enterprise value	$83.8M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
IPO Date	1999-11-08
Isin	US68237V1035
Last refreshed	2026-07-31
Market cap	$89.9M
Market cap category	Micro-Cap
Price	$0.75
Price currency	USD
Sector	Healthcare
Sector PE	45.21
Sector PE Fwd	23.64
Sic	2834
Symbol	ONCY
Website	https://oncolyticsbiotech.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-37.49%
FCF yield	-25.54%

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Net Income	$-33.3M
Net Income Growth Years	0%
Profit Per Employee	$-1.1M
ROA	-188.5
Roa5y	-77.35
ROCE	-923.2
ROIC	-6,967.5

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-13.29%
Cagr15y	-23.57%
Cagr1y	-26.19%
Cagr20y	-15.59%
Cagr3y	-35.52%
Cagr5y	-20.56%
EPS Growth Years	0
Revenue Growth Years	0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	$8.2M
Cash	$5.5M
Current Assets	$7.5M
Current Liabilities	$5.4M
Debt	$508,000
Equity	$-5.1M
Liabilities	$13.3M
Long Term Assets	$674,000
Long Term Liabilities	$7.9M
Net Cash	$5M
Net Cash By Market Cap	$5.61
Net Cash Growth	-49.9%
Tangible Book Value	$-5.1M
Tangible Book Value Per Share	$-0.04
WACC	10.21

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.38
Net Working Capital	$-3.3M
Quick ratio	1.19
Working Capital	$2.1M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-30.37%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-75.98%
1Y total return	-26.18%
200-day SMA	0.97
3Y total return	-73.2%
50-day SMA	0.87
50-day SMA vs 200-day SMA	50under200
5Y total return	-68.36%
All Time High	93.48
All Time High Change	-99.19%
All Time High Date	2004-04-05
All Time Low	0.33
All Time Low Change	131.12%
All Time Low Date	2025-06-06
ATR	0.06
Beta	1.09
Beta1y	2.18
Beta2y	1.28
Ch YTD	-13.84
High	0.77
High52	1.51
High52 Date	2025-09-29
High52ch	-50.13%
Low	0.73
Low52	0.73
Low52 Date	2026-07-30
Low52ch	3.14%
Ma50ch	-13.8%
Premarket Change Percent	-0.21
Premarket Price	$0.75
Premarket Volume	9,211
Price vs 200-day SMA	-22.59%
RSI	35.39
RSI Monthly	43.97
RSI Weekly	42.89
Sharpe ratio	0.02x
Sortino ratio	0.11
Total Return	-30.37%
Tr YTD	-13.84
Tr15y	-98.23%
Tr1m	-21.68%
Tr1w	-11.23%
Tr3m	-13.55%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	6
Analyst Count Top	2
Analyst Price Target Top	$10
Analyst Ratings	Buy
Analyst Ratings Top	Buy
Earnings EPS Estimate	$-0.07
Operating Income	$-33M
Price target	$5.05
Price Target Change	$571
Price Target Change Top	$1,228

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	116,895,002%
Float Percent	97.94%
Shares Insiders	2.06%
Shares Institutions	3.55%
Shares Out	119,354,067
Shares Qo Q	5.64%
Shares Yo Y	30.37%
Short Ratio	5.18
Short Shares	6.79

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-30.7M
Adjusted OCF	-30,697,000
Average Volume	1,609,360.4x
Bv Per Share	-0.04
CAPEX	$-11,000
Ch10y	-75.98
Ch15y	-98.23
Ch1m	-21.68
Ch1w	-11.23
Ch1y	-26.18
Ch20y	-96.63
Ch3m	-13.55
Ch3y	-73.2
Ch5y	-68.36
Ch6m	-25.45
Change	0.19%
Change From Open	-0.75
Close	0.75
Days Gap	0.94
Depreciation Amortization	67,000
Dollar Volume	751,795.2
Earnings Date	2026-08-07
Earnings Time	bmo
EBIT	$-25.3M
EBITDA	$-34.6M
EPS	$-0.32
F Score	1
FCF	$-22.7M
FCF EV Yield	-27.06x
FCF Per Share	$-0.19
Financing CF	17,551,000
Fiscal Year End	December
Founded	1,998
Income Tax	$79,000
Investing CF	-11,000
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-14
Last Report Date	2026-03-31
Last Split Date	2018-05-25
Last Split Type	Reverse
Last10k Filing Date	2026-03-30
Ma150	0.94
Ma150ch	-20.23%
Ma20	0.85
Ma20ch	-11.44%
Net CF	-5,152,000
Next Earnings Date	2026-08-11
Open	0.76
Optionable	No
Position In Range	63.79
Post Close	0.75
Postmarket Change Percent	-1.71
Postmarket Price	$0.74
Ppne	674,000
Pre Close	0.75
Price Date	2026-07-30
Relative Volume	0.62x
Share Based Comp	8,025,000
Tr20y	-96.63%
Tr6m	-25.45%
Us State	California
Volume	998,400

Oncolytics Biotech Inc. (ONCY)

Coverage state: Market snapshot only — no published research

Generate the first ONCY analysis

Price

Financial snapshot

Fair-value bridge

Analyst consensus

Latest news · ONCY

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All ONCY indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on ONCY

Frequently asked questions